Brilliant Violet 510™ anti-mouse Ly-6A/E (Sca-1)

Antibodies Single
Sony
D7
Flow Cytometry
Rat IgG2a, κ
Mouse
IL-2-dependent mouse T-cell line (CTL-L)
125 µl
1140645
$203.00

Description

Ly-6A/E, also known as Sca-1, is an 18 kD member of the Ly-6 multigene family. Ly6A/E is a glycosylphosphatidylinositol (GPI)-linked protein expressed on hematopoietic stem cells. In mice expressing the Ly-6.2 haplotype (e.g., AKR, C57BL, C57BR, DBA/2, SJL, SWR, and 129), Ly-6A/E is also expressed on peripheral B lymphocytes and thymic and peripheral T lymphocytes. Strains expressing the Ly-6.1 haplotype (e.g., BALB/c, CBA, C3H/He, DBA/1, and NZB) have low Ly-6A/E expression on resting peripheral lymphocytes. The expression of Ly-6A/E on lymphocytes is upregulated upon activation from both Ly6.1 and Ly6.2 haplotype mice. Ly-6A/E is thought to be involved in the regulation of both T and B cell responses.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Ortega G, et al. 1986. J. Immunol. 137:3240. (WB, IP)
2. Palfree RGE, et al. 1986. Immunogenetics 23:197. (WB)
3. Codias EK, et al. 1990. J. Immunol. 144:2197.
4. Malek TR, et al. 1986. J. Exp. Med. 164:709.
5. Codias EK, et al. 1990. J. Immunol. 145:1407.
6. Ivanov V, et al. 1994. J. Immunol. 153:2394.
7. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
8. Fleming T, et al. 1994. J. Immunol. 153:1955.
9. van Bragt MPA, et al. 2005. Biol. Reprod. 73:634. (IF, IHC)
10. Umland O, et al. 2007. J. Immunol. 178:4147.
11. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 45:149. (FC) PubMed
12. Pronk CJ, et al. 2011. J. Exp Med. PubMed
13. English A, et al. 2000. J. Immunol. 165:3763. (IHC)
14. Bamezai A and Rock KL. 1995. Proc. Natl. Acad. Sci. USA 92:4294.